AndroScience Corporation, a privately held biotech company, has successfully filed an IND for acne indication and will proceed with Human Clinical Trials in the first quarter of 2007. AndroScience has developed its lead compound ASC-J9, a novel anti-androgen that enhances androgen receptor degradation, into a topical cream for acne treatment that will be tested in the clinical trials. [click link ...
From: www.medicalnewstoday.com
AndroScience Corporation Enters Clinical Stage
Posted by Ruslan Abuzant at 1:13 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment